Affiliations: [a] Center for Health + Technology, University of Rochester Medical Center, Rochester, NY, USA
| [b] Department of Neurology, University of Rochester Medical Center, Rochester, NY, USA
Correspondence:
[*]
Correspondence to: Monica Javidnia, PhD, 265 Crittenden Blvd., Saunders Research Building, Box 420694, Rochester, NY 14642, USA. Tel.: +1 585 275 1122; Fax: +1 585 461 3554;
E-mail: [email protected].
Abstract: Parkinson’s disease (PD) patients experience a range of non-motor symptoms that are believed to be related to disease pathophysiology, many of which are treatable by medications. Among newly-diagnosed PD participants in the Parkinson’s Progression Markers Initiative study, we describe (1) the frequency of medication use for common non-motor symptoms, and (2) when non-motor symptomatic treatment was initiated relative to PD diagnosis. Non-motor medication use was reported by 73% of participants, most commonly for depression, constipation, and anxiety. Treatment of some non-motor symptoms, notably depression, antedated diagnosis. These data may be useful for studies of non-motor symptoms in PD.
